Skip to content

Clinical trials

Phase 1/2 Multiple Myeloma trials in Israel

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Myeloma Phase: Phase 1/2 Country / region: Israel Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20102
20162
20172
20201
20211
20221
20231
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting4
Active, not recruiting3
Completed3
Terminated1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie2
Sheba Medical Center2
Bayer1
Biokine Therapeutics Ltd1
Celgene1
GlaxoSmithKline1
Hoffmann-La Roche1
Janssen Research & Development, LLC1
Mirror Biologics, Inc.1
Teva Branded Pharmaceutical Products R&D LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Myeloma13
Lymphoma2
Neoplasms2
Recurrence2
Hematologic Neoplasms1
Hodgkin Disease1
Leukemia1
Leukemia, Lymphocytic, Chronic, B-Cell1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive1
Lymphoma, Non-Hodgkin1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.